Dexamethasone and Thromboangiitis obliterans - a phase IV clinical study of FDA data


Thromboangiitis obliterans is reported only by a few people who take Dexamethasone.

The phase IV clinical study analyzes which people take Dexamethasone and have Thromboangiitis obliterans. It is created by eHealthMe based on reports of 105,970 people who have side effects while taking Dexamethasone from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 18, 2023

105,970 people reported to have side effects when taking Dexamethasone.
Among them, 3 people (0.0%) have Thromboangiitis obliterans.

What is Dexamethasone?

Dexamethasone has active ingredients of dexamethasone. It is often used in multiple myeloma. eHealthMe is studying from 106,611 Dexamethasone users for its effectiveness, alternative drugs and more.

What is Thromboangiitis obliterans?

Thromboangiitis obliterans (a rare disease of the arteries and veins in the arms and legs) is found to be associated with 165 drugs and 83 conditions by eHealthMe.

Number of Dexamethasone and Thromboangiitis obliterans reports submitted per year:

Could Dexamethasone cause Thromboangiitis obliterans?

Gender of people who have Thromboangiitis obliterans when taking Dexamethasone *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Thromboangiitis obliterans when taking Dexamethasone *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 100 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Dexamethasone *:

  1. Zevalin: 2 people, 66.67%
  2. Lamictal: 2 people, 66.67%

Common side effects people have besides Thromboangiitis obliterans *:

  1. Thrombocytopenia (decrease of platelets in blood): 2 people, 66.67%
  2. Stomatitis (inflammation of mucous membrane of mouth): 2 people, 66.67%
  3. Leukopenia (less number of white blood cells in blood): 2 people, 66.67%
  4. Gangrene (body tissue dies): 2 people, 66.67%
  5. Pain: 1 person, 33.33%
  6. Onychomadesis (a periodic idiopathic shedding of the nails): 1 person, 33.33%
  7. Necrosis (the death of body tissue): 1 person, 33.33%
  8. Nail Disorder (disease of nail): 1 person, 33.33%
  9. Malignant Neoplasm Progression (cancer tumour came back): 1 person, 33.33%
  10. Haematotoxicity (toxins that destroy red blood cells): 1 person, 33.33%

Common conditions people have *:

  1. Central Nervous System Lymphoma (cancer of central nervous system forms in lymph tissue): 2 people, 66.67%
  2. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Dexamethasone and have Thromboangiitis obliterans?

Check whether Thromboangiitis obliterans is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Thromboangiitis obliterans and when was it recovered:

Expand to all the drugs that have ingredients of dexamethasone:

Alternative drugs to, pros and cons of Dexamethasone:

Common Dexamethasone side effects:

Browse all side effects of Dexamethasone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Thromboangiitis obliterans treatments and more:

COVID vaccines that are related to Thromboangiitis obliterans:

All the drugs that are associated with Thromboangiitis obliterans:

All the conditions that are associated with Thromboangiitis obliterans:

How the study uses the data?

The study uses data from the FDA. It is based on dexamethasone (the active ingredients of Dexamethasone) and Dexamethasone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: